Michael Barbella, Managing Editor12.06.23
OrthoPediatrics Corp. has launched a new division focused on non-surgical intervention for pediatric orthopedics. The OrthoPediatrics Specialty Bracing division (OPSB) will serve as a flagship house of brands and innovative products that expand the company’s total addressable market by rouoghly $600 million.
OrthoPediatrics first entered the non-operative space through the acquisition of MD Orthopaedics Inc. (MDO) in 2022 and its bracing product lines and the patented Mitchell Ponseti Ankle-Foot Orthosis (AFO) system for clubfoot treatment. Since the transaction, the company has been building a portfolio of complementary products to address the large unmet needs for specialty bracing within the pediatric orthopedic market. Earlier this year, MDO acquired the assets of Rhino Pediatric Orthopedic Designs Inc., a San Diego-based firm founded by two pediatric orthopedic surgeons. The Rhino “Kicker” and “Cruiser” braces were designed for children with developmental hip dysplasia.
Additionally, OrthoPediatrics released the DF2 Brace as part of its expansion in the non-surgical business for treating kids with musculoskeletal injuries. The DF2 Brace is intended for femur fracture fixation in pediatric patients from approximately 6 months to 5 years of age; the brace immobilizes the femur, knee, and hip, rescuing kids from the confines of a spica cast. Most recently, the company announced a new partnership with Montreal-based Ora Medical to distribute The Levity, a gait-trainer device designed for children with walking difficulties.
OrthoPediatrics President of Trauma & Deformity Correction Joe Hauser will lead the new non-operative business. “We are excited for the launch of the new OPSB division, and our continued expansion into pediatric orthopedic non-surgical treatments for kids. This new addition advances our growth strategy of providing a broad product portfolio uniquely designed to treat children while surrounding pediatric orthopedic surgeons with the most comprehensive product offering in the market,” he said.
Founded in 2006, OrthoPediatrics focuses exclusively on advancing the pediatric orthopedics field. As such it has developed a comprehensive product offering to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 53 products that span trauma and deformity, scoliosis, and sports medicine/other procedures. The company's global sales team sells and distributes its products in the United States and more than 70 countries worldwide.
OrthoPediatrics first entered the non-operative space through the acquisition of MD Orthopaedics Inc. (MDO) in 2022 and its bracing product lines and the patented Mitchell Ponseti Ankle-Foot Orthosis (AFO) system for clubfoot treatment. Since the transaction, the company has been building a portfolio of complementary products to address the large unmet needs for specialty bracing within the pediatric orthopedic market. Earlier this year, MDO acquired the assets of Rhino Pediatric Orthopedic Designs Inc., a San Diego-based firm founded by two pediatric orthopedic surgeons. The Rhino “Kicker” and “Cruiser” braces were designed for children with developmental hip dysplasia.
Additionally, OrthoPediatrics released the DF2 Brace as part of its expansion in the non-surgical business for treating kids with musculoskeletal injuries. The DF2 Brace is intended for femur fracture fixation in pediatric patients from approximately 6 months to 5 years of age; the brace immobilizes the femur, knee, and hip, rescuing kids from the confines of a spica cast. Most recently, the company announced a new partnership with Montreal-based Ora Medical to distribute The Levity, a gait-trainer device designed for children with walking difficulties.
OrthoPediatrics President of Trauma & Deformity Correction Joe Hauser will lead the new non-operative business. “We are excited for the launch of the new OPSB division, and our continued expansion into pediatric orthopedic non-surgical treatments for kids. This new addition advances our growth strategy of providing a broad product portfolio uniquely designed to treat children while surrounding pediatric orthopedic surgeons with the most comprehensive product offering in the market,” he said.
Founded in 2006, OrthoPediatrics focuses exclusively on advancing the pediatric orthopedics field. As such it has developed a comprehensive product offering to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 53 products that span trauma and deformity, scoliosis, and sports medicine/other procedures. The company's global sales team sells and distributes its products in the United States and more than 70 countries worldwide.